|
UGT8 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.2952000823866E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.72320002711501E-09 |
| Normal-vs-Stage2 |
2.09399999999693E-05 |
| Normal-vs-Stage3 |
5.12150322151683E-11 |
| Normal-vs-Stage4 |
1.28042021430019E-12 |
| Stage1-vs-Stage2 |
1.033230E-01 |
| Stage1-vs-Stage3 |
4.782600E-01 |
| Stage1-vs-Stage4 |
4.10499999999869E-05 |
| Stage2-vs-Stage3 |
8.160200E-02 |
| Stage2-vs-Stage4 |
5.154500E-04 |
| Stage3-vs-Stage4 |
5.097500E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.37240005418471E-10 |
| Normal-vs-AfricanAmerican |
5.006300E-04 |
| Normal-vs-Asian |
6.80888678772362E-12 |
| Caucasian-vs-AfricanAmerican |
4.083200E-01 |
| Caucasian-vs-Asian |
3.425700E-02 |
| AfricanAmerican-vs-Asian |
1.408380E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.447000297361E-10 |
| Normal-vs-Female |
2.36630004479821E-09 |
| Male-vs-Female |
1.132840E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.83789999780504E-10 |
| Normal-vs-Age(41-60Yrs) |
1.08599995662928E-09 |
| Normal-vs-Age(61-80Yrs) |
9.12580000456131E-08 |
| Normal-vs-Age(81-100Yrs) |
5.32730000113446E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.818600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.689430E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.582000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.816000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.501400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.235900E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.392300E-04 |
| Classical-VS-Follicular |
1.5442299999946E-05 |
| Classical-VS-Other |
6.489800E-01 |
| Classical-VS-Normal |
1.14609988166592E-10 |
| Tall-VS-Follicular |
3.6198000152865E-09 |
| Tall-VS-Other |
1.190230E-01 |
| Tall-VS-Normal |
6.63247234911069E-13 |
| Follicular-VS-Other |
4.576100E-02 |
| Follicular-VS-Normal |
1.638620E-03 |
| Other-VS-Normal |
1.187790E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.85039999673387E-08 |
| Normal-vs-N1 |
2.31337171641144E-12 |
| N0-vs-N1 |
2.37630000121669E-08 |
|
|
